a lot of 'baby' bios are getting hacked up. CRMD for example just rec'd FDA approval of a compound that WILL become the standard of care because of its effectiveness. And despite the news, since the 'launch' isn't till (later?) in the 1st qtr 2024, its gone 'no where' on the news.
ATNM has gotten clocked, but what the heck, given a target price of $20+ (if they would stop selling frigging shares), its a 'gift' at these prices. But like CRMD, its going to have to EXECUTE (get approved and get sales going).
Got 1 other that has very good potential, but again, folks just don't seem to be interested in something that isn't 'doing'
I was just browsing thru their website, going over their Nov presentation. Was looking for an update on the BLA filing, see someone posted its now into the 1H 2024. Was going to start accumulating, but a look at the chart is indicating $4 may not hold now. So going to continue to be patient. Cause I suspect given the early stages for the rest of their effort (and years to an endpoint), the only thing that might turn this around would be news of the filing. And with that pushed back? LIke CRMD, the market is not being kind to baby bios. Course the other thing is, when the market turns from 'no price is too high' to lets get 'real''? Whats a 'fair value' takes on a whole different perspective. (example: Sava back when it was completing a PH 2 hit over $120/sh look at where its at now..and I would argue its still overvalued given what they have PROVEN)
Disclaimer: still being patient to buy back in.. And getting it down here just increases the potential reward if they can get approved)
Bullish
